Alexandru Dinulescu

Dr. Alexandru Dinulescu

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ADAlexandru Dinulescu
Alexandru Dinulescu
APAlexandru-Sorin Păsărică
Alexandru-Sorin Păsărică
MCMadalina Carp
Madalina Carp
ADAndrei Dușcă
Andrei Dușcă
IDIrina Dijmărescu
Irina Dijmărescu
Alexandru UliciAlexandru Ulici
Alexandru Ulici
(1) Background: Osteogenesis imperfecta (OI) is a rare skeletal dysplasia characterized as a heterogeneous disorder group with well-defined phenotypic and genetic features that share uncommon bone fragility. The current treatment options, medical and orthopedic, are limited and not efficient enough to improve the low bone density, bone fragility, growth, and mobility of the affected individuals, creating the need for alternative therapeutic agents. (2) Methods: We searched the medical database to find papers regarding treatments for OI other than conventional ones. We included 45 publications. (3) Results: In reviewing the literature, eight new potential therapies for OI were identified, proving promising results in cells and animal models or in human practice, but further research is still needed. Bone marrow transplantation is a promising therapy in mice, adults, and children, decreasing the fracture rate with a beneficial effect on structural bone proprieties. Anti-RANKL antibodies generated controversial results related to the therapy schedule, from no change in the fracture rate to improvement in the bone mineral density resorption markers and bone formation, but with adverse effects related to hypercalcemia. Sclerostin inhibitors in murine models demonstrated an increase in the bone formation rate and trabecular cortical bone mass, and a few human studies showed an increase in biomarkers and BMD and the downregulation of resorption markers. Recombinant human parathormone and TGF-β generated good results in human studies by increasing BMD, depending on the type of OI. Gene therapy, 4-phenylbutiric acid, and inhibition of eIF2α phosphatase enzymes have only been studied in cell cultures and animal models, with promising results. (4) Conclusions: This paper focuses on eight potential therapies for OI, but there is not yet enough data for a new, generally accepted treatment. Most of them showed promising results, but further research is needed, especially in the pediatric field.

24 August 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
DPDaniela Pacurar
Daniela Pacurar
ADAlexandru Dinulescu
Alexandru Dinulescu
Andrei-Vlad TotuAndrei-Vlad Totu
Andrei-Vlad Totu
IDIrina Dijmărescu
Irina Dijmărescu
MPMirela Luminita Pavelescu
Mirela Luminita Pavelescu
Background: Urinary tract infections (UTIs) are among the most common bacterial infections in children, with Escherichia coli as the leading pathogen. The rise in antimicrobial resistance, particularly extended-spectrum β-lactamase (ESBL) production, complicates empirical therapy, especially in countries with limited surveillance like Romania. Methods: We conducted a retrospective study on 248 pediatric patients aged 0–17 years diagnosed with E. coli UTI and admitted to a children hospital from Bucharest, Romania, between 2022 and 2024. Data collected included clinical presentation, laboratory values, and antimicrobial susceptibility testing. Patients were divided into ESBL and non-ESBL groups, and statistical comparisons were performed using SPSS v25. Results: Infants accounted for 68.1% of cases, with male sex predominating in this group (85.3%). ESBL-producing strains were identified in 19% of patients, more frequently in males (25% vs. 13.6%, p = 0.024). While inflammatory markers (CRP, leukocytes, neutrophils) were higher in complicated infections, they were paradoxically lower in ESBL cases. Non-ESBL isolates were highly susceptible to fosfomycin, third-generation cephalosporins, nitrofurantoin, and gentamicin. ESBL isolates showed resistance to most β-lactams but retained high susceptibility to fosfomycin (100%), carbapenems (>89%), cefoxitin (89.4%), and amikacin (85.1%). Conclusions: Our findings support the use of fosfomycin, nitrofurantoin, and selected aminoglycosides as viable empirical options in pediatric UTIs. Given the substantial ESBL prevalence and resistance to commonly used oral agents, local antibiogram data should guide empirical treatment strategies to preserve antibiotic efficacy and combat resistance.

7 March 2024 in Life
Verified
Journal Article
Open access
PDF file
DPDaniela Pacurar
Daniela Pacurar
ADAlexandru Dinulescu
Alexandru Dinulescu
JGJugulete Gheorghita
Jugulete Gheorghita
APAlexandru-Sorin Păsărică
Alexandru-Sorin Păsărică
IDIrina Dijmărescu
Irina Dijmărescu
Hepatitis B virus (HBV) is a frequent cause of chronic hepatitis worldwide, with an estimated 5.6 million children under 5 years being infected. In Romania, there are no available epidemiology reports on large cohorts in children. We aimed to assess the profile of pediatric chronic HBV infection in southern Romania. We conducted an observational retrospective study on 506 HBV-infected children. Based on alaninaminotransferase (ALT), HBV serology and viremia, we identified four states of the disease. We correlated age, gender, household HBV infection, coinfection with other viruses and laboratory parameters. Most patients were in a positive HBV envelope antigen (HBeAg) immune-active state (65.4%). Age at diagnosis was significantly lower for those with household infection (p < 0.05). ALT values were not significantly different between positive or negative HBeAg patients in the immune-active state (p = 0.780). ALT values were higher in patients with hepatitis D virus (HDV)-associated infection (p < 0.001). Children with a household HBV infection had a high viraemia more frequently when compared to those with no infected relative (79.3% vs. 67.4%) (p < 0.001), but the ALT values were not significantly different (p = 0.21). Most of the patients are in an immune-active state (high ALT, high viremia). The percentages of HBV- and HDV-associated infections are high, but lower than the reported prevalence in Romania in the general population.

15 February 2024 in Frontiers in Pediatrics
Verified
Journal Article
Open access
MPMirela Luminița Pavelescu
Mirela Luminița Pavelescu
ADAlexandru Dinulescu
Alexandru Dinulescu
APAlexandru-Sorin Păsărică
Alexandru-Sorin Păsărică
IDIrina Dijmărescu
Irina Dijmărescu
DPDaniela Păcurar
Daniela Păcurar
Background: Complete blood count, C-reactive protein and transaminases are routine laboratory parameters investigated in children with infections, including COVID 19. We aimed to evaluate the diagnostic accuracy of these parameters in children diagnosed with COVID 19.Methods: At the time of admission, children with COVID 19 suggestive symptoms were tested RT-PCR for SARS CoV-2 and were allocated to either the study group (RT-PCR SARS CoV-2 positive) or control group (RT-PCR SARS CoV-2 negative). All children were evaluated by complete blood count, CRP, and transaminases.Results: When comparing the two groups, we identified significantly lower values for leukocytes (p < 0.001), neutrophils (p < 0.001), lymphocytes (p < 0.001) and thrombocytes (p = 0.014), but no significantly different values for CRP (p = 0.916) and monocytes (p = 0.082). A diagnostic score for COVID-19 was compiled using the abovementioned parameters—presence of fever, number of lymphocytes and aspartate-aminotransferase. Performance was tested, showing a positive discrimination value (AUC of 0.703)—81.5% sensitivity, 50.6% specificity.Conclusions: The leukocytes, neutrophils and lymphocytes have significantly lower values in COVID-19 children. The proposed score based on the presence of fever the values of lymphocytes and AST has a good sensitivity in predicting COVID-19 infection.

26 March 2025 in Medicina
Verified
Journal Article
Open access
PDF file
AJAna Maria Cristina Jura
Ana Maria Cristina Jura
Daniela-Eugenia PopescuDaniela-Eugenia Popescu
Daniela-Eugenia Popescu
CCCitu Cosmin
Citu Cosmin
MBMarius Biris
Marius Biris
CPCorina Pienar
Corina Pienar
IRIoana Rosca
Ioana Rosca
Background and Objectives: Patent ductus arteriosus (PDA) is common in newborns, being associated with high morbidity and mortality. While maternal and neonatal conditions are known contributors, few studies use advanced machine learning (ML) as predictive factors. This study assessed how maternal pathologies, medications, and neonatal factors affect the risk of PDA using traditional statistics and ML algorithms: Random Forest (RF) and XGBoost (XGB). Materials and Methods: A retrospective 3-year cohort study of 201 NICU neonates assessed maternal and neonatal factors. Logistic regression (LR) and chi-square analyses identified significant predictors, while ML models enhanced predictive accuracy and pinpointed key PDA factors. Results: LR identified prolonged rupture of membranes (>18 h) as the most significant predictor (OR: 13.03, p < 0.001). The ML models identified gestational age, maternal anemia, prenatal care level, birth weight, prolonged rupture of membranes, medication usage, diabetes, pregnancy-induced hypertension, SARS-CoV-2 infection, and cervical cerclage as key predictors. The RF model had 76.3% accuracy, moderate sensitivity (47.4%), and high specificity (90%). XGB performed better with 81.4% accuracy, an AUC of 0.872, sensitivity of 92.5%, and specificity of 57.9%. Conclusions: This study shows that maternal and neonatal factors significantly influence the risk of PDA. ML, particularly XGBoost, enhances predictive abilities, guiding targeted interventions and improving neonatal outcomes.

Verified
Journal Article
Open access
PDF file
ADAnca Cristina Drăgănescu
Anca Cristina Drăgănescu
ADAlexandru Dinulescu
Alexandru Dinulescu
DPDaniela Pacurar
Daniela Pacurar
Viorel JingaViorel Jinga
Viorel Jinga
DPDoina-Anca Anca Plesca
Doina-Anca Anca Plesca
Background/Objectives: Overweight and obesity in children is a worldwide health concern, with a high prevalence and an increasing trend in recent years. The prevalence of pediatric overweight and obesity in Romania is unclear; some studies estimate the rate of overweight at 15–20% and the obesity rate at 8.7–10.7%. The objective of this study is to measure the prevalence of overweight and obesity in children in Romania and to highlight their risks and protective factors. Methods: A repeated cross-sectional study that included children between 5 and 17 years old was performed across 2 years. Anamnestic data regarding demographics, family, and child’s lifestyle was collected from the child’s parent, and some medical and anthropometric parameters of the child were measured. The BMI and z-scores were calculated using the WHO charts. Logistic regression models were verified for goodness-of-fit and used for estimating the prediction value of fast-food consumption, parents’ education, and the presence of parents with obesity in the case of increased weight in the child. Results: A total of 1231 children were included in the study, 25.1% of whom exhibited an excess of weight. The prevalences of overweight and obesity were 17.5% and 7.6%, respectively. In the multivariate model, the following variables significantly predicted the weight of children: days of fast-food consumption, parents’ education, parents with excess weight, and hours of physical activity (p < 0.005) Conclusions: The prevalence of pediatric overweight and obesity in Romania is in accordance with the global prevalence. Considering fast-food consumption and the presence of parents with obesity as risk factors for children’s overweight or obesity and physical activity and a higher level of education of the parent as protector factors, we strongly emphasize the importance of public health initiatives directed towards these factors.